Are you Dr. Milano?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 15 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-677-5925- Is this information wrong?
Summary
- Dr. Filippo Milano, MD is a hematologist in Seattle, Washington. He is currently licensed to practice medicine in Washington and Idaho. He is affiliated with Fred Hutchinson Cancer Center and UW Medicine/University of Washington Medical Center.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2013 - 2016
Sapienza University of RomeClass of 2001
Certifications & Licensure
WA State Medical License 2009 - 2025
ID State Medical License 2022 - 2024
Clinical Trials
- Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes Start of enrollment: 2022 May 10
- Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers Start of enrollment: 2022 Oct 06
- US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia Start of enrollment: 2020 Nov 13
- Join now to see all
Publications & Presentations
PubMed
- Impact of socioeconomic disparities on outcomes in adults undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukemia.Daniel J Olivieri, Megan Othus, Corentin Orvain, Eduardo Rodríguez-Arbolí, Filippo Milano, Brenda M Sandmaier, Irum Khan, Chris Davis, Ryan S Basom, Frederick R Appelb...> ;Leukemia. 2024 Apr 1
- Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with MDS/AML or AML.Corentin Orvain, Naveed Ali, Megan Othus, Eduardo Rodríguez-Arbolí, Filippo Milano, Calvin M Le, Brenda M Sandmaier, Bart L Scott, Frederick R Appelbaum, Roland B Walter> ;American Journal of Hematology. 2024 Feb 21
- 1 citationsTiming of anti-PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma.Hirayama, A., Kimble, E., Wright, J., Fiorenza, S., Gauthier, J., Voutsinas, J., Wu, Q., Yeung, C., Gazeau, N., Pender, B., Kirchmeier, D., Torkelson, A., Chutnik, A.,...> ;Blood Advances. 2024 Jan 23
- Join now to see all
Press Mentions
Testing Cord Blood Transplants as a Cure for Leukemia — and HIVMarch 10th, 2022
Fred Hutch at ASH: Press Briefing on CAR T-cell Therapy, CRISPR for Blood Disorders, MoreNovember 26th, 2018
Cord Blood Transplantation Proves Beneficial in High-Risk Patients with LeukemiaOctober 10th, 2017- Join now to see all
Hospital Affiliations
Fred Hutchinson Cancer CenterSeattle, Washington
UW Medicine/University of Washington Medical CenterSeattle, Washington
